{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:25:38Z","timestamp":1759335938279,"version":"3.37.3"},"reference-count":127,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T00:00:00Z","timestamp":1657756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T00:00:00Z","timestamp":1657756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiol med"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s11547-022-01522-4","type":"journal-article","created":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T11:03:35Z","timestamp":1657796615000},"page":"899-911","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Management of cutaneous melanoma: radiologists challenging and risk assessment"],"prefix":"10.1007","volume":"127","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6601-3221","authenticated-orcid":false,"given":"Vincenza","family":"Granata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igino","family":"Simonetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio Venanzio","family":"Setola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Izzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Scarpato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vito","family":"Vanella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Festino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ester","family":"Simeone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo Antonio","family":"Ascierto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Petrillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,14]]},"reference":[{"issue":"3","key":"1522_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"1522_CR2","unstructured":"https:\/\/www.who.int\/data\/gho\/data\/themes\/mortality-and-global-health-estimates\/ghe-leading-causes-of-death"},{"issue":"6","key":"1522_CR3","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1111\/bjd.19705","volume":"184","author":"R Laskar","year":"2021","unstructured":"Laskar R, Ferreiro-Iglesias A, Bishop DT, Iles MM, Kanetsky PA, Armstrong BK, Law MH, Goldstein AM, Aitken JF, Giles GG (2021) Australian Melanoma Family Study Investigators; Leeds Case-Control Study Investigators, Risk factors for melanoma by anatomical site: an evaluation of aetiological heterogeneity. Br J Dermatol 184(6):1085\u20131093. https:\/\/doi.org\/10.1111\/bjd.19705","journal-title":"Br J Dermatol"},{"issue":"21","key":"1522_CR4","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.1093\/hmg\/ddaa222","volume":"29","author":"E Mangantig","year":"2021","unstructured":"Mangantig E, MacGregor S, Iles MM, Scolyer RA, Cust AE, Hayward NK, Montgomery GW, Duffy DL, Thompson JF, Henders A, Bowdler L, Rowe C, Cadby G, Mann GJ, Whiteman DC, Long GV, Ward SV, Khosrotehrani K, Barrett JH, Law MH (2021) Germline variants are associated with increased primary melanoma tumor thickness at diagnosis. Hum Mol Genet 29(21):3578\u20133587. https:\/\/doi.org\/10.1093\/hmg\/ddaa222","journal-title":"Hum Mol Genet"},{"key":"1522_CR5","doi-asserted-by":"publisher","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","volume":"27","author":"CM Balch","year":"2009","unstructured":"Balch CM, Gershenwald JE, Soong S-J, Thompson JF, Atkins MB, Byrd DR, Buzaid AC, Cochran AJ, Coit DG, Ding S et al (2009) Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 27:6199\u20136206","journal-title":"J Clin Oncol"},{"key":"1522_CR6","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1245\/s10434-018-6513-7","volume":"25","author":"JE Gershenwald","year":"2018","unstructured":"Gershenwald JE, Scolyer RA (2018) Melanoma staging: American joint committee on cancer (AJCC) and beyond. Ann Surg Oncol 25:2105\u20132110","journal-title":"Ann Surg Oncol"},{"key":"1522_CR7","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1097\/00000658-197011000-00017","volume":"172","author":"A Breslow","year":"1970","unstructured":"Breslow A (1970) Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 172:902\u2013908","journal-title":"Ann Surg"},{"issue":"1","key":"1522_CR8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3892\/etm.2021.10998","volume":"23","author":"F Sandru","year":"2022","unstructured":"Sandru F, Dumitrascu MC, Petca A, Carsote M, Petca RC, Ghemigian A (2022) Melanoma in patients with Li-Fraumeni syndrome (Review). Exp Ther Med 23(1):75. https:\/\/doi.org\/10.3892\/etm.2021.10998","journal-title":"Exp Ther Med"},{"issue":"14","key":"1522_CR9","doi-asserted-by":"publisher","first-page":"877","DOI":"10.2147\/JMDH.S306284","volume":"21","author":"DNA Ningrum","year":"2021","unstructured":"Ningrum DNA, Yuan SP, Kung WM, Wu CC, Tzeng IS, Huang CY, Li JY, Wang YC (2021) Deep learning classifier with Patient\u2019s metadata of dermoscopic images in malignant melanoma detection. J Multidiscip Healthc 21(14):877\u2013885. https:\/\/doi.org\/10.2147\/JMDH.S306284","journal-title":"J Multidiscip Healthc"},{"issue":"30","key":"1522_CR10","doi-asserted-by":"publisher","first-page":"30394","DOI":"10.18632\/oncotarget.4724","volume":"6","author":"A Avallone","year":"2015","unstructured":"Avallone A, Pecori B, Bianco F, Aloj L, Tatangelo F, Romano C, Granata V, Marone P, Leone A, Botti G, Petrillo A, Carac\u00f2 C, Iaffaioli VR, Muto P, Romano G, Comella P, Budillon A, Delrio P (2015) Critical role of bevacizumab scheduling in combination with pre-surgical chemo-radiotherapy in MRI-defined high-risk locally advanced rectal cancer: Results of the BRANCH trial. Oncotarget 6(30):30394\u201330407. https:\/\/doi.org\/10.18632\/oncotarget.4724","journal-title":"Oncotarget"},{"issue":"10","key":"1522_CR11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13027-015-0016-y","volume":"29","author":"S Bimonte","year":"2015","unstructured":"Bimonte S, Leongito M, Barbieri A, Del Vecchio V, Barbieri M, Albino V, Piccirillo M, Amore A, Di Giacomo R, Nasto A, Granata V, Petrillo A, Arra C, Izzo F (2015) Inhibitory effect of (-)-epigallocatechin-3-gallate and bleomycin on human pancreatic cancer MiaPaca-2 cell growth. Infect Agent Cancer 29(10):22. https:\/\/doi.org\/10.1186\/s13027-015-0016-y","journal-title":"Infect Agent Cancer"},{"issue":"12","key":"1522_CR12","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1007\/s11547-021-01414-z","volume":"126","author":"F Cellini","year":"2021","unstructured":"Cellini F, Di Franco R, Manfrida S, Borzillo V, Maranzano E, Pergolizzi S, Morganti AG, Fusco V, Deodato F, Santarelli M, Arcidiacono F, Rossi R, Reina S, Merlotti A, Jereczek-Fossa BA, Tozzi A, Siepe G, Cacciola A, Russi E, Gambacorta MA, Scorsetti M, Ricardi U, Corv\u00f2 R, Donato V, Muto P, Valentini V (2021) Palliative radiotherapy indications during the COVID-19 pandemic and in future complex logistic settings: the NORMALITY model. Radiol Med 126(12):1619\u20131656. https:\/\/doi.org\/10.1007\/s11547-021-01414-z","journal-title":"Radiol Med"},{"issue":"12","key":"1522_CR13","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1007\/s11547-021-01412-1","volume":"126","author":"MAM Hussein","year":"2021","unstructured":"Hussein MAM, Cafarelli FP, Paparella MT, Rennie WJ, Guglielmi G (2021) Phosphaturic mesenchymal tumors: radiological aspects and suggested imaging pathway. Radiol Med 126(12):1609\u20131618. https:\/\/doi.org\/10.1007\/s11547-021-01412-1","journal-title":"Radiol Med"},{"issue":"12","key":"1522_CR14","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1007\/s11547-021-01408-x","volume":"126","author":"G Danti","year":"2021","unstructured":"Danti G, Flammia F, Matteuzzi B, Cozzi D, Berti V, Grazzini G, Pradella S, Recchia L, Brunese L, Miele V (2021) Gastrointestinal neuroendocrine neoplasms (GI-NENs): hot topics in morphological, functional, and prognostic imaging. Radiol Med 126(12):1497\u20131507. https:\/\/doi.org\/10.1007\/s11547-021-01408-x","journal-title":"Radiol Med"},{"issue":"9","key":"1522_CR15","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1097\/IGC.0000000000000825","volume":"26","author":"G Laurelli","year":"2016","unstructured":"Laurelli G, Falcone F, Gallo MS, Scala F, Losito S, Granata V, Cascella M, Greggi S (2016) Long-term oncologic and reproductive outcomes in young women with early endometrial cancer conservatively treated: a prospective study and literature update. Int J Gynecol Cancer 26(9):1650\u20131657. https:\/\/doi.org\/10.1097\/IGC.0000000000000825","journal-title":"Int J Gynecol Cancer"},{"issue":"13","key":"1522_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13027-018-0194-5","volume":"3","author":"V Granata","year":"2018","unstructured":"Granata V, Fusco R, Filice S, Catalano O, Piccirillo M, Palaia R, Izzo F, Petrillo A (2018) The current role and future prospectives of functional parameters by diffusion weighted imaging in the assessment of histologic grade of HCC. Infect Agent Cancer 3(13):23. https:\/\/doi.org\/10.1186\/s13027-018-0194-5","journal-title":"Infect Agent Cancer"},{"issue":"1","key":"1522_CR17","doi-asserted-by":"publisher","first-page":"10953","DOI":"10.1038\/s41598-019-47548-z","volume":"9","author":"D Rega","year":"2019","unstructured":"Rega D, Pace U, Scala D, Chiodini P, Granata V, Fares Bucci A, Pecori B, Delrio P (2019) Treatment of splenic flexure colon cancer: a comparison of three different surgical procedures: experience of a high volume cancer center. Sci Rep 9(1):10953. https:\/\/doi.org\/10.1038\/s41598-019-47548-z","journal-title":"Sci Rep"},{"issue":"31","key":"1522_CR18","doi-asserted-by":"publisher","first-page":"51224","DOI":"10.18632\/oncotarget.17227","volume":"8","author":"V Granata","year":"2017","unstructured":"Granata V, Fusco R, Avallone A, Filice F, Tatangelo F, Piccirillo M, Grassi R, Izzo F, Petrillo A (2017) Critical analysis of the major and ancillary imaging features of LI-RADS on 127 proven HCCs evaluated with functional and morphological MRI: Lights and shadows. Oncotarget 8(31):51224\u201351237. https:\/\/doi.org\/10.18632\/oncotarget.17227","journal-title":"Oncotarget"},{"issue":"5","key":"1522_CR19","doi-asserted-by":"publisher","first-page":"8143","DOI":"10.18632\/oncotarget.14106","volume":"8","author":"A Petrillo","year":"2017","unstructured":"Petrillo A, Fusco R, Petrillo M, Granata V, Delrio P, Bianco F, Pecori B, Botti G, Tatangelo F, Carac\u00f2 C, Aloj L, Avallone A, Lastoria S (2017) Standardized Index of Shape (DCE-MRI) and Standardized Uptake Value (PET\/CT): two quantitative approaches to discriminate chemo-radiotherapy locally advanced rectal cancer responders under a functional profile. Oncotarget 8(5):8143\u20138153. https:\/\/doi.org\/10.18632\/oncotarget.14106","journal-title":"Oncotarget"},{"issue":"12","key":"1522_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13027-017-0168-z","volume":"30","author":"R Fusco","year":"2017","unstructured":"Fusco R, Sansone M, Granata V, Setola SV, Petrillo A (2017) A systematic review on multiparametric MR imaging in prostate cancer detection. Infect Agent Cancer 30(12):57. https:\/\/doi.org\/10.1186\/s13027-017-0168-z","journal-title":"Infect Agent Cancer"},{"issue":"12","key":"1522_CR21","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1007\/s11547-021-01406-z","volume":"126","author":"M De Filippo","year":"2021","unstructured":"De Filippo M, Puglisi S, D\u2019Amuri F, Gentili F, Paladini I, Carrafiello G, Maestroni U, Del Rio P, Ziglioli F, Pagnini F (2021) CT-guided percutaneous drainage of abdominopelvic collections: a pictorial essay. Radiol Med 126(12):1561\u20131570. https:\/\/doi.org\/10.1007\/s11547-021-01406-z","journal-title":"Radiol Med"},{"issue":"11","key":"1522_CR22","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1007\/s11547-021-01404-1","volume":"126","author":"C Cannataci","year":"2021","unstructured":"Cannataci C, Cimo\u2019 B, Mamone G, Tuzzolino F, D\u2019Amico M, Cortis K, Maruzzelli L, Miraglia R (2021) Portal vein puncture-related complications during transjugular intrahepatic portosystemic shunt creation: colapinto needle set vs R\u00f6sch-Uchida needle set. Radiol Med 126(11):1487\u20131495. https:\/\/doi.org\/10.1007\/s11547-021-01404-1","journal-title":"Radiol Med"},{"issue":"9","key":"1522_CR23","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s00270-021-02904-3","volume":"44","author":"AH Mahnken","year":"2021","unstructured":"Mahnken AH, Boullosa Seoane E, Cannavale A, de Haan MW, Dezman R, Kloeckner R, O\u2019Sullivan G, Ryan A, Tsoumakidou G (2021) CIRSE Clinical Practice Manual. Cardiovasc Intervent Radiol 44(9):1323\u20131353. https:\/\/doi.org\/10.1007\/s00270-021-02904-3","journal-title":"Cardiovasc Intervent Radiol"},{"key":"1522_CR24","doi-asserted-by":"publisher","first-page":"469097","DOI":"10.1155\/2013\/469097","volume":"2013","author":"V Granata","year":"2013","unstructured":"Granata V, Petrillo M, Fusco R, Setola SV, de Castelguidone E, Catalano O, Piccirillo M, Albino V, Izzo F, Petrillo A (2013) Surveillance of HCC patients after Liver RFA: role of MRI with Hepatospecific contrast versus three-phase CT scan-experience of high volume oncologic institute. Gastroenterol Res Pract. 2013:469097. https:\/\/doi.org\/10.1155\/2013\/469097","journal-title":"Gastroenterol Res Pract."},{"issue":"6","key":"1522_CR25","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.12669\/pjms.336.12905","volume":"33","author":"S Nasir","year":"2017","unstructured":"Nasir S, Anwar S, Ahmed M (2017) Multidisciplinary team (MDT) meeting and Radiologist workload, a prospective review in a tertiary care hospital. Pak J Med Sci. 33(6):1501\u20131506. https:\/\/doi.org\/10.12669\/pjms.336.12905","journal-title":"Pak J Med Sci."},{"issue":"8","key":"1522_CR26","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s11547-021-01373-5","volume":"126","author":"MA Ruffino","year":"2021","unstructured":"Ruffino MA, Fronda M, Bergamasco L, Natrella M, Fanelli G, Bellosta R, Pegorer M, Attisani L, Ruggiero M, Malfa P, Patane\u2019 D, Lucatelli P, Corona M, Ricci C, Candeloro L, Ferri M, Varello S, Gibello L, Veraldi GF, Mezzetto L, Fonio P (2021) Prognostic risk factors for loss of patency after femoro popliteal bailout stenting with dual-component stent: results from the TIGRIS Italian Multicenter Registry. Radiol Med 126(8):1129\u20131137. https:\/\/doi.org\/10.1007\/s11547-021-01373-5","journal-title":"Radiol Med"},{"issue":"7","key":"1522_CR27","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s11547-021-01356-6","volume":"126","author":"F Giurazza","year":"2021","unstructured":"Giurazza F, Contegiacomo A, Calandri M, Mosconi C, Modestino F, Corvino F, Scrofani AR, Marra P, Coniglio G, Failla G, Lucarelli N, Femia M, Semeraro V, Ierardi AM (2021) IVC filter retrieval: a multicenter proposal of two score systems to predict application of complex technique and procedural outcome. Radiol Med 126(7):1007\u20131016. https:\/\/doi.org\/10.1007\/s11547-021-01356-6","journal-title":"Radiol Med"},{"issue":"1","key":"1522_CR28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.neo.2021.11.013","volume":"24","author":"Z Li","year":"2022","unstructured":"Li Z, Fang Y, Chen H, Zhang T, Yin X, Man J, Yang X, Lu M (2022) Spatiotemporal trends of the global burden of melanoma in 204 countries and territories from 1990 to 2019: results from the 2019 global burden of disease study. Neoplasia 24(1):12\u201321. https:\/\/doi.org\/10.1016\/j.neo.2021.11.013","journal-title":"Neoplasia"},{"issue":"12","key":"1522_CR29","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1038\/s41436-021-01292-w","volume":"23","author":"AK Smit","year":"2021","unstructured":"Smit AK, Allen M, Beswick B, Butow P, Dawkins H, Dobbinson SJ, Dunlop KL, Espinoza D, Fenton G, Kanetsky PA, Keogh L, Kimlin MG, Kirk J, Law MH, Lo S, Low C, Mann GJ, Reyes-Marcelino G, Morton RL, Newson AJ, Savard J, Trevena L, Wordsworth S, Cust AE (2021) Impact of personal genomic risk information on melanoma prevention behaviors and psychological outcomes: a randomized controlled trial. Genet Med 23(12):2394\u20132403. https:\/\/doi.org\/10.1038\/s41436-021-01292-w","journal-title":"Genet Med"},{"issue":"5","key":"1522_CR30","doi-asserted-by":"publisher","first-page":"942","DOI":"10.2214\/AJR.16.16800","volume":"208","author":"VK Wong","year":"2017","unstructured":"Wong VK, Lubner MG, Menias CO, Mellnick VM, Kennedy TA, Bhalla S, Pickhardt PJ (2017) Clinical and imaging features of Noncutaneous Melanoma. AJR Am J Roentgenol 208(5):942\u2013959. https:\/\/doi.org\/10.2214\/AJR.16.16800","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"1522_CR31","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1600-0846.2011.00503.x","volume":"17","author":"L Smith","year":"2011","unstructured":"Smith L, Macneil S (2011) State of the art in non-invasive imaging of cutaneous melanoma. Skin Res Technol 17(3):257\u2013269. https:\/\/doi.org\/10.1111\/j.1600-0846.2011.00503.x","journal-title":"Skin Res Technol"},{"issue":"Suppl 1","key":"1522_CR32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s40257-018-0373-6","volume":"19","author":"R Cabrera","year":"2018","unstructured":"Cabrera R, Recule F (2018) Unusual clinical presentations of malignant melanoma: a review of clinical and histologic features with special emphasis on Dermatoscopic findings. Am J Clin Dermatol 19(Suppl 1):15\u201323. https:\/\/doi.org\/10.1007\/s40257-018-0373-6","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"1522_CR33","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.sder.2007.12.006","volume":"27","author":"A Esmaeili 4th","year":"2008","unstructured":"Esmaeili A 4th, Scope A, Halpern AC, Marghoob AA (2008) Imaging techniques for the in vivo diagnosis of melanoma. Semin Cutan Med Surg 27(1):2\u201310. https:\/\/doi.org\/10.1016\/j.sder.2007.12.006 (PMID: 18486018)","journal-title":"Semin Cutan Med Surg"},{"issue":"7","key":"1522_CR34","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s11547-021-01366-4","volume":"126","author":"Y Nakamura","year":"2021","unstructured":"Nakamura Y, Higaki T, Honda Y, Tatsugami F, Tani C, Fukumoto W, Narita K, Kondo S, Akagi M, Awai K (2021) Advanced CT techniques for assessing hepatocellular carcinoma. Radiol Med 126(7):925\u2013935. https:\/\/doi.org\/10.1007\/s11547-021-01366-4","journal-title":"Radiol Med"},{"issue":"9","key":"1522_CR35","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s11547-021-01382-4","volume":"126","author":"J Li","year":"2021","unstructured":"Li J, Cao B, Bi X, Chen W, Wang L, Du Z, Zhang X, Yu X (2021) Evaluation of liver function in patients with chronic hepatitis B using Gd-EOB-DTPA-enhanced T1 mapping at different acquisition time points: a feasibility study. Radiol Med 126(9):1149\u20131158. https:\/\/doi.org\/10.1007\/s11547-021-01382-4","journal-title":"Radiol Med"},{"issue":"1","key":"1522_CR36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11547-019-01092-y","volume":"125","author":"A Esposito","year":"2020","unstructured":"Esposito A, Buscarino V, Raciti D, Casiraghi E, Manini M, Biondetti P, Forzenigo L (2020) Characterization of liver nodules in patients with chronic liver disease by MRI: performance of the Liver Imaging Reporting and Data System (LI-RADS vol 2018) scale and its comparison with the Likert scale. Radiol Med 125(1):15\u201323. https:\/\/doi.org\/10.1007\/s11547-019-01092-y (Epub 2019 Oct 5)","journal-title":"Radiol Med"},{"issue":"5","key":"1522_CR37","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S1470-2045(09)70036-1","volume":"10","author":"M Lens","year":"2009","unstructured":"Lens M, Bataille V, Krivokapic Z (2009) Melanoma of the small intestine. Lancet Oncol 10(5):516\u2013521. https:\/\/doi.org\/10.1016\/S1470-2045(09)70036-1","journal-title":"Lancet Oncol"},{"issue":"6","key":"1522_CR38","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/s0033-8389(05)70233-5","volume":"36","author":"MF Mafee","year":"1998","unstructured":"Mafee MF (1998) Uveal melanoma, choroidal hemangioma, and simulating lesions. Role of MR imaging. Radiol Clin North Am. 36(6):1083\u201399. https:\/\/doi.org\/10.1016\/s0033-8389(05)70233-5","journal-title":"Radiol Clin North Am."},{"issue":"1","key":"1522_CR39","first-page":"93","volume":"94","author":"N Lassau","year":"2007","unstructured":"Lassau N, Chami L, Peronneau P (2007) Imagerie des m\u00e9lanomes: performances de l\u2019\u00e9chographie sans et avec injection de produit de contraste pour le diagnostic et l\u2019\u00e9valuation des traitements [Imaging of melanoma: accuracy of ultrasonography before and after contrast injection for diagnostic and early evaluation of treatments]. Bull Cancer 94(1):93\u20138","journal-title":"Bull Cancer"},{"issue":"10","key":"1522_CR40","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1097\/RLI.0b013e31828eea67","volume":"48","author":"K Erb-Eigner","year":"2013","unstructured":"Erb-Eigner K, Willerding G, Taupitz M, Hamm B, Asbach P (2013) Diffusion-weighted imaging of ocular melanoma. Invest Radiol 48(10):702\u2013707. https:\/\/doi.org\/10.1097\/RLI.0b013e31828eea67 (PMID: 23614974)","journal-title":"Invest Radiol"},{"issue":"3","key":"1522_CR41","first-page":"554","volume":"70","author":"U Hani","year":"2020","unstructured":"Hani U, Bakhshi SK, Shamim MS (2020) Primary intracranial malignant Melanoma. J Pak Med Assoc 70(3):554\u2013556","journal-title":"J Pak Med Assoc"},{"issue":"1","key":"1522_CR42","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1684\/ejd.2014.2481","volume":"25","author":"C Viallard","year":"2015","unstructured":"Viallard C, Perrot Y, Boudhraa Z, Jouberton E, Miot-Noirault E, Bonnet M, Besse S, Mishellany F, Cayre A, Maigne L, Rbah-Vidal L, D\u2019Incan M, Cachin F, Chezal JM, Degoul F (2015) [123I]ICF01012 melanoma imaging and [131I]ICF01012 dosimetry allow adapted internal targeted radiotherapy in preclinical melanoma models. Eur J Dermatol 25(1):29\u201335. https:\/\/doi.org\/10.1684\/ejd.2014.2481","journal-title":"Eur J Dermatol"},{"issue":"6","key":"1522_CR43","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/srt.12891","volume":"26","author":"G Hirano","year":"2020","unstructured":"Hirano G, Nemoto M, Kimura Y, Kiyohara Y, Koga H, Yamazaki N, Christensen G, Ingvar C, Nielsen K, Nakamura A, Sota T, Nagaoka T (2020) Automatic diagnosis of melanoma using hyperspectral data and GoogLeNet. Skin Res Technol 26(6):891\u2013897. https:\/\/doi.org\/10.1111\/srt.12891","journal-title":"Skin Res Technol"},{"issue":"5","key":"1522_CR44","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.suc.2014.07.001","volume":"94","author":"RM Kauffmann","year":"2014","unstructured":"Kauffmann RM, Chen SL (2014) Workup and staging of malignant melanoma. Surg Clin North Am. 94(5):963\u201372. https:\/\/doi.org\/10.1016\/j.suc.2014.07.001","journal-title":"Surg Clin North Am."},{"issue":"8","key":"1522_CR45","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1245\/s10434-018-6513-7","volume":"25","author":"JE Gershenwald","year":"2018","unstructured":"Gershenwald JE, Scolyer RA (2018) Melanoma Staging: American Joint Committee on Cancer (AJCC) and Beyond. Ann Surg Oncol. 25(8):2105\u20132110. https:\/\/doi.org\/10.1245\/s10434-018-6513-7","journal-title":"Ann Surg Oncol."},{"key":"1522_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000520751","volume":"13","author":"A Laverde-Saad","year":"2022","unstructured":"Laverde-Saad A, Simard A, Nassim D, Jfri A, Alajmi A, O\u2019Brien E, Wortsman X (2022) Performance of ultrasound for identifying morphological characteristics and thickness of cutaneous basal cell carcinoma: a systematic review. Dermatology 13:1\u201319. https:\/\/doi.org\/10.1159\/000520751","journal-title":"Dermatology"},{"issue":"1","key":"1522_CR47","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11547-020-01324-6","volume":"126","author":"A Barile","year":"2021","unstructured":"Barile A (2021) Some thoughts and greetings from the new Editor-in-Chief. Radiol Med 126(1):3\u20134. https:\/\/doi.org\/10.1007\/s11547-020-01324-6","journal-title":"Radiol Med"},{"issue":"11","key":"1522_CR48","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1007\/s11547-021-01396-y","volume":"126","author":"C Ossola","year":"2021","unstructured":"Ossola C, Curti M, Calvi M, Tack S, Mazzoni S, Genesio L, Venturini M, Genovese EA (2021) Role of ultrasound and magnetic resonance imaging in the prognosis and classification of muscle injuries in professional football players: correlation between imaging and return to sport time. Radiol Med 126(11):1460\u20131467. https:\/\/doi.org\/10.1007\/s11547-021-01396-y","journal-title":"Radiol Med"},{"issue":"10","key":"1522_CR49","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s11547-021-01386-0","volume":"126","author":"E Soyer G\u00fcldo\u011fan","year":"2021","unstructured":"Soyer G\u00fcldo\u011fan E, Ergun O, Ta\u015fk\u0131n T\u00fcrkmeno\u011flu T, Y\u0131lmaz KB, Akda\u011f T, \u00d6zbal G\u00fcne\u015f S, Durmaz HA, Hekimo\u011flu B (2021) The impact of TI-RADS in detecting thyroid malignancies: a prospective study. Radiol Med 126(10):1335\u20131344. https:\/\/doi.org\/10.1007\/s11547-021-01386-0","journal-title":"Radiol Med"},{"issue":"9","key":"1522_CR50","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1007\/s11547-021-01349-5","volume":"126","author":"I Celletti","year":"2021","unstructured":"Celletti I, Fresilli D, De Vito C, Bononi M, Cardaccio S, Cozzolino A, Durante C, Grani G, Grimaldi G, Isidori AM, Catalano C, Cantisani V (2021) TIRADS, SRE and SWE in INDETERMINATE thyroid nodule characterization: which has better diagnostic performance? Radiol Med 126(9):1189\u20131200. https:\/\/doi.org\/10.1007\/s11547-021-01349-5","journal-title":"Radiol Med"},{"issue":"6","key":"1522_CR51","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/CMR.0000000000000782","volume":"31","author":"A Janowska","year":"2021","unstructured":"Janowska A, Oranges T, Iannone M, Davini G, Suraci S, Fidanzi C, Granieri G, Romanelli M, Dini V (2021) Ultra-high-frequency ultrasound monitoring of melanomas arising in congenital melanocytic nevi: a case series. Melanoma Res 31(6):561\u2013565. https:\/\/doi.org\/10.1097\/CMR.0000000000000782","journal-title":"Melanoma Res"},{"issue":"10","key":"1522_CR52","doi-asserted-by":"publisher","first-page":"951","DOI":"10.3390\/jpm11100951","volume":"11","author":"JM Jung","year":"2021","unstructured":"Jung JM, Cho JY, Lee WJ, Chang SE, Lee MW, Won CH (2021) Emerging minimally invasive technologies for the detection of skin cancer. J Pers Med 11(10):951. https:\/\/doi.org\/10.3390\/jpm11100951","journal-title":"J Pers Med"},{"key":"1522_CR53","doi-asserted-by":"publisher","first-page":"e62527","DOI":"10.3791\/62527","volume":"175","author":"M Vitiello","year":"2021","unstructured":"Vitiello M, Kusmic C, Faita F, Poliseno L (2021) Analysis of lymph node volume by ultra-high-frequency ultrasound imaging in the Braf\/Pten genetically engineered mouse model of melanoma. J Vis Exp 175:e62527. https:\/\/doi.org\/10.3791\/62527","journal-title":"J Vis Exp"},{"issue":"4","key":"1522_CR54","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s40477-019-00379-0","volume":"22","author":"O Catalano","year":"2019","unstructured":"Catalano O, Rold\u00e1n FA, Varelli C, Bard R, Corvino A, Wortsman X (2019) Skin cancer: findings and role of high-resolution ultrasound. J Ultrasound 22(4):423\u2013431. https:\/\/doi.org\/10.1007\/s40477-019-00379-0","journal-title":"J Ultrasound"},{"issue":"7","key":"1522_CR55","doi-asserted-by":"publisher","first-page":"E179","DOI":"10.1055\/s-0032-1312827","volume":"33","author":"U Marone","year":"2012","unstructured":"Marone U, Catalano O, Carac\u00f2 C, Anniciello AM, Sandomenico F, Di Monta G, Di Cecilia ML, Mori S, Botti G, Petrillo A, Mozzillo N (2012) Can high-resolution ultrasound avoid the sentinel lymph-node biopsy procedure in the staging process of patients with stage I-II cutaneous melanoma? Ultraschall Med 33(7):E179\u2013E185. https:\/\/doi.org\/10.1055\/s-0032-1312827","journal-title":"Ultraschall Med"},{"key":"1522_CR56","doi-asserted-by":"publisher","first-page":"5614","DOI":"10.1200\/JCO.2008.21.4882","volume":"27","author":"A Sanki","year":"2009","unstructured":"Sanki A, Uren RF, Moncrieff M et al (2009) Targeted high-resolution ultrasound is not an effective substitute for sentinel lymph node biopsy in patients with primary cutaneous melanoma. J Clin Oncol 27:5614\u20135619","journal-title":"J Clin Oncol"},{"issue":"12","key":"1522_CR57","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1093\/annonc\/mdz411","volume":"30","author":"O Michielin","year":"2019","unstructured":"Michielin O, van Akkooi ACJ, Ascierto PA, Dummer R, Keilholz U (2019) ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2020. Ann Oncol. 30(12):1884\u20131901. https:\/\/doi.org\/10.1093\/annonc\/mdz411","journal-title":"Ann Oncol."},{"issue":"11","key":"1522_CR58","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.annonc.2020.07.004","volume":"31","author":"U Keilholz","year":"2020","unstructured":"Keilholz U, Ascierto PA, Dummer R, Robert C, Lorigan P, van Akkooi A, Arance A, Blank CU, Chiarion Sileni V, Donia M, Faries MB, Gaudy-Marqueste C, Gogas H, Grob JJ, Guckenberger M, Haanen J, Hayes AJ, Hoeller C, Lebb\u00e9 C, Lugowska I, Mandal\u00e0 M, M\u00e1rquez-Rodas I, Nathan P, Neyns B, Olofsson Bagge R, Puig S, Rutkowski P, Schilling B, Sondak VK, Tawbi H, Testori A, Michielin O (2020) ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee. Ann Oncol 31(11):1435\u20131448. https:\/\/doi.org\/10.1016\/j.annonc.2020.07.004 (Epub 2020 Aug 4)","journal-title":"Ann Oncol"},{"key":"1522_CR59","unstructured":"https:\/\/www.aiom.it\/wp-content\/uploads\/2020\/10\/2020_LG_AIOM_Melanoma.pdf"},{"issue":"35","key":"1522_CR60","doi-asserted-by":"publisher","first-page":"4641","DOI":"10.1200\/JCO.2010.34.2956","volume":"29","author":"RM Turner","year":"2011","unstructured":"Turner RM, Bell KJL, Morton RL et al (2011) Optimizing the frequency of follow-up visits for patients treated for localized primary cutaneous melanoma. J Clin Oncol 29(35):4641\u20134646","journal-title":"J Clin Oncol"},{"issue":"28","key":"1522_CR61","doi-asserted-by":"publisher","first-page":"4774","DOI":"10.1200\/JCO.2008.20.1822","volume":"27","author":"E Bastiaannet","year":"2009","unstructured":"Bastiaannet E, Wobbes T, Hoekstra OS et al (2009) Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment. J Clin Oncol 27(28):4774\u20134780","journal-title":"J Clin Oncol"},{"issue":"2","key":"1522_CR62","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.soc.2005.12.005","volume":"15","author":"OE Nieweg","year":"2006","unstructured":"Nieweg OE, Kroon B (2006) The conundrum of follow-up: should it be aban- doned? Surg Oncol Clin N Am 15(2):319\u2013330","journal-title":"Surg Oncol Clin N Am"},{"issue":"4","key":"1522_CR63","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1097\/SLA.0000000000003405","volume":"273","author":"JF Thompson","year":"2021","unstructured":"Thompson JF, Haydu LE, Uren RF, Andtbacka RH, Zager JS, Beitsch PD, Agnese DM, Mozzillo N, Testori A, Bowles TL, Hoekstra HJ, Kelley MC, Sussman J, Schneebaum S, Smithers BM, McKinnon G, Hsueh E, Jacobs L, Schultz E, Reintgen D, Kane JM, Friedman EB, Wang H, Van Kreuningen L, Schiller V, Elashoff DA, Elashoff R, Cochran AJ, Stern S, Faries MB (2021) MSLT-II Trial Group. Preoperative ultrasound assessment of regional lymph nodes in melanoma patients does not provide reliable nodal staging: results from a large multicenter trial. Ann Surg. 273(4):814\u2013820. https:\/\/doi.org\/10.1097\/SLA.0000000000003405 (PMID: 31188198)","journal-title":"Ann Surg."},{"key":"1522_CR64","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/CMR.0b013e328348dad3","volume":"21","author":"U Kruger","year":"2011","unstructured":"Kruger U, Kretschmer L, Thoms KM et al (2011) Lymph node ultrasound during melanoma follow-up significantly improves metastasis detection compared with clinical examination alone: a study on 433 patients. Melanoma Res 21:457\u2013463","journal-title":"Melanoma Res"},{"key":"1522_CR65","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/00008390-200304000-00012","volume":"13","author":"MH Schmid-Wendtner","year":"2003","unstructured":"Schmid-Wendtner MH, Paerschke G, Baumert J et al (2003) Value of ultrasonogra- phy compared with physical examination for the detection of locoregional metastases in patients with cutaneous melanoma. Melanoma Res 13:183\u2013188","journal-title":"Melanoma Res"},{"key":"1522_CR66","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1002\/1097-0142(20010615)91:12<2409::AID-CNCR1275>3.0.CO;2-S","volume":"91","author":"C Voit","year":"2001","unstructured":"Voit C, Mayer T, Kron M et al (2001) Efficacy of ultrasound B-scan compared with physical examination in follow-up of melanoma patients. Cancer 91:2409\u20132416","journal-title":"Cancer"},{"key":"1522_CR67","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1093\/jnci\/djq455","volume":"103","author":"Y Xing","year":"2011","unstructured":"Xing Y, Bronstein Y, Ross MI et al (2011) Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta- analysis. J Natl Cancer Inst 103:129\u2013142","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"1522_CR68","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1007\/s11547-020-01191-1","volume":"125","author":"J Sun","year":"2020","unstructured":"Sun J, Yang L, Zhou Z, Zhang D, Han W, Zhang Q, Peng Y (2020) Performance evaluation of two iterative reconstruction algorithms, MBIR and ASIR, in low radiation dose and low contrast dose abdominal CT in children. Radiol Med 125(10):918\u2013925. https:\/\/doi.org\/10.1007\/s11547-020-01191-1","journal-title":"Radiol Med"},{"issue":"6","key":"1522_CR69","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s11547-021-01341-z","volume":"126","author":"G Cicero","year":"2021","unstructured":"Cicero G, Mazziotti S, Silipigni S, Blandino A, Cantisani V, Pergolizzi S, D\u2019Angelo T, Stagno A, Maimone S, Squadrito G, Ascenti G (2021) Dual-energy CT quantification of fractional extracellular space in cirrhotic patients: comparison between early and delayed equilibrium phases and correlation with oesophageal varices. Radiol Med 126(6):761\u2013767. https:\/\/doi.org\/10.1007\/s11547-021-01341-z","journal-title":"Radiol Med"},{"issue":"4","key":"1522_CR70","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3390\/jpm11040285","volume":"11","author":"V D'Agostino","year":"2021","unstructured":"D\u2019Agostino V, Caranci F, Negro A, Piscitelli V, Tuccillo B, Fasano F, Sirabella G, Marano I, Granata V, Grassi R, Pupo D, Grassi R (2021) A rare case of cerebral venous thrombosis and disseminated intravascular coagulation temporally associated to the COVID-19 vaccine administration. J Pers Med 11(4):285. https:\/\/doi.org\/10.3390\/jpm11040285","journal-title":"J Pers Med"},{"issue":"9","key":"1522_CR71","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.3390\/cancers12092665","volume":"12","author":"R Fusco","year":"2020","unstructured":"Fusco R, Granata V, Petrillo A (2020) Introduction to special issue of radiology and imaging of Cancer. Cancers 12(9):2665. https:\/\/doi.org\/10.3390\/cancers12092665","journal-title":"Cancers"},{"issue":"5","key":"1522_CR72","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.2214\/AJR.14.12509","volume":"204","author":"V Granata","year":"2015","unstructured":"Granata V, Fusco R, Catalano O, Piccirillo M, De Bellis M, Izzo F, Petrillo A (2015) Percutaneous ablation therapy of hepatocellular carcinoma with irreversible electroporation: MRI findings. AJR Am J Roentgenol 204(5):1000\u20131007. https:\/\/doi.org\/10.2214\/AJR.14.12509","journal-title":"AJR Am J Roentgenol"},{"issue":"12","key":"1522_CR73","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1007\/s11547-021-01428-7","volume":"126","author":"V Granata","year":"2021","unstructured":"Granata V, Grassi R, Fusco R, Setola SV, Belli A, Ottaiano A, Nasti G, La Porta M, Danti G, Cappabianca S, Cutolo C, Petrillo A, Izzo F (2021) Intrahepatic cholangiocarcinoma and its differential diagnosis at MRI: how radiologist should assess MR features. Radiol Med 126(12):1584\u20131600. https:\/\/doi.org\/10.1007\/s11547-021-01428-7","journal-title":"Radiol Med"},{"issue":"6","key":"1522_CR74","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1007\/s11547-020-01134-w","volume":"125","author":"F Arrigoni","year":"2020","unstructured":"Arrigoni F, Bruno F, Gianneramo C, Palumbo P, Zugaro L, Zoccali C, Barile A, Masciocchi C (2020) Evolution of the imaging features of osteoid osteoma treated with RFA or MRgFUS during a long-term follow-up: a pictorial review with clinical correlations. Radiol Med 125(6):578\u2013584. https:\/\/doi.org\/10.1007\/s11547-020-01134-w","journal-title":"Radiol Med"},{"issue":"11","key":"1522_CR75","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s11547-020-01289-6","volume":"125","author":"P Palumbo","year":"2020","unstructured":"Palumbo P, Cannizzaro E, Di Cesare A, Bruno F, Schicchi N, Giovagnoni A, Splendiani A, Barile A, Masciocchi C, Di Cesare E (2020) Cardiac magnetic resonance in arrhythmogenic cardiomyopathies. Radiol Med 125(11):1087\u20131101. https:\/\/doi.org\/10.1007\/s11547-020-01289-6","journal-title":"Radiol Med"},{"issue":"12","key":"1522_CR76","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1007\/s11547-021-01416-x","volume":"126","author":"A Mirabile","year":"2021","unstructured":"Mirabile A, Lucarelli NM, Sollazzo EP, Stabile Ianora AA, Sardaro A, Mirabile G, Lorusso F, Racanelli V, Maggialetti N, Scardapane A (2021) CT pulmonary angiography appropriateness in a single emergency department: does the use of revised Geneva score matter? Radiol Med 126(12):1544\u20131552. https:\/\/doi.org\/10.1007\/s11547-021-01416-x","journal-title":"Radiol Med"},{"issue":"4","key":"1522_CR77","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/SLA.0b013e31824a5742","volume":"255","author":"E Bastiaannet","year":"2012","unstructured":"Bastiaannet E, Uyl-de Groot CA, Brouwers AH, van der Jagt EJ, Hoekstra OS, Oyen W, Verzijlbergen F, van Ooijen B, Thompson JF, Hoekstra HJ (2012) Cost-effectiveness of adding FDG-PET or CT to the diagnostic work-up of patients with stage III melanoma. Ann Surg 255(4):771\u2013776. https:\/\/doi.org\/10.1097\/SLA.0b013e31824a5742","journal-title":"Ann Surg"},{"issue":"23","key":"1522_CR78","doi-asserted-by":"publisher","first-page":"8395","DOI":"10.1002\/cam4.4342","volume":"10","author":"AC Eggen","year":"2021","unstructured":"Eggen AC, Wind TT, Bosma I, Kramer MCA, van Laar PJ, van der Weide HL, Hospers GAP, Jalving M (2021) Value of screening and follow-up brain MRI scans in patients with metastatic melanoma. Cancer Med 10(23):8395\u20138404. https:\/\/doi.org\/10.1002\/cam4.4342","journal-title":"Cancer Med"},{"issue":"9","key":"1522_CR79","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.26355\/eurrev_202105_25829","volume":"25","author":"I Simonetti","year":"2021","unstructured":"Simonetti I, Sandomenico F, Rocco MP, Fusco R, Setola SV, Granata V, Iasevoli DM, Ascierto PA, Grassi R, Petrillo A (2021) Metastatic endo and perineural involvement of the ulnar nerve from malignant melanoma: ultrasound (US) and magnetic resonance imaging (MRI) findings. Eur Rev Med Pharmacol Sci 25(9):3478\u20133482. https:\/\/doi.org\/10.26355\/eurrev_202105_25829","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1522_CR80","unstructured":"Networks National Comprehensive Cancer. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Cutaneous Melanoma. Version 1.2021. https:\/\/www.nccn.org\/ professionals\/physician_gls\/pdf\/cns_blocks.pdf"},{"issue":"1","key":"1522_CR81","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa1504030","volume":"373","author":"J Larkin","year":"2015","unstructured":"Larkin J, Chiarion-Sileni V, Gonzalez R, Grob JJ, Cowey CL, Lao CD, Schadendorf D, Dummer R, Smylie M, Rutkowski P, Ferrucci PF, Hill A, Wagstaff J, Carlino MS, Haanen JB, Maio M, Marquez-Rodas I, McArthur GA, Ascierto PA, Long GV, Callahan MK, Postow MA, Grossmann K, Sznol M, Dreno B, Bastholt L, Yang A, Rollin LM, Horak C, Hodi FS, Wolchok JD (2015) Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma. N Engl J Med 373(1):23\u201334. https:\/\/doi.org\/10.1056\/NEJMoa1504030","journal-title":"N Engl J Med"},{"issue":"11","key":"1522_CR82","doi-asserted-by":"publisher","first-page":"5592","DOI":"10.3390\/ijerph18115592","volume":"18","author":"V Granata","year":"2021","unstructured":"Granata V, Fusco R, Salati S, Petrillo A, Di Bernardo E, Grassi R, Palaia R, Danti G, La Porta M, Cadossi M, Ga\u0161ljevi\u0107 G, Sersa G, Izzo F (2021) A systematic review about imaging and Histopathological findings for detecting and evaluating electroporation based treatments response. Int J Environ Res Public Health 18(11):5592. https:\/\/doi.org\/10.3390\/ijerph18115592","journal-title":"Int J Environ Res Public Health"},{"issue":"16","key":"1522_CR83","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1056\/NEJMoa1910836","volume":"381","author":"J Larkin","year":"2019","unstructured":"Larkin J, Chiarion-Sileni V, Gonzalez R, Grob JJ, Rutkowski P, Lao CD, Cowey CL, Schadendorf D, Wagstaff J, Dummer R, Ferrucci PF, Smylie M, Hogg D, Hill A, M\u00e1rquez-Rodas I, Haanen J, Guidoboni M, Maio M, Sch\u00f6ffski P, Carlino MS, Lebb\u00e9 C, McArthur G, Ascierto PA, Daniels GA, Long GV, Bastholt L, Rizzo JI, Balogh A, Moshyk A, Hodi FS, Wolchok JD (2019) Five-year survival with combined Nivolumab and Ipilimumab in advanced Melanoma. N Engl J Med 381(16):1535\u20131546. https:\/\/doi.org\/10.1056\/NEJMoa1910836","journal-title":"N Engl J Med"},{"key":"1522_CR84","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.critrevonc.2017.01.019","volume":"112","author":"PA Ascierto","year":"2017","unstructured":"Ascierto PA, Accorona R, Botti G, Farina D, Fossati P, Gatta G, Gogas H, Lombardi D, Maroldi R, Nicolai P, Ravanelli M, Vanella V (2017) Mucosal melanoma of the head and neck. Crit Rev Oncol Hematol 112:136\u2013152. https:\/\/doi.org\/10.1016\/j.critrevonc.2017.01.019","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"1522_CR85","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1056\/NEJMoa1412082","volume":"372","author":"C Robert","year":"2015","unstructured":"Robert C, Long GV, Brady B, Dutriaux C, Maio M, Mortier L, Hassel JC, Rutkowski P, McNeil C, Kalinka-Warzocha E, Savage KJ, Hernberg MM, Lebb\u00e9 C, Charles J, Mihalcioiu C, Chiarion-Sileni V, Mauch C, Cognetti F, Arance A, Schmidt H, Schadendorf D, Gogas H, Lundgren-Eriksson L, Horak C, Sharkey B, Waxman IM, Atkinson V, Ascierto PA (2015) Nivolumab in previously untreated melanoma without BRAF mutation. N Engl J Med 372(4):320\u2013330. https:\/\/doi.org\/10.1056\/NEJMoa1412082","journal-title":"N Engl J Med"},{"issue":"33","key":"1522_CR86","doi-asserted-by":"publisher","first-page":"3947","DOI":"10.1200\/JCO.20.00198","volume":"38","author":"R Seth","year":"2020","unstructured":"Seth R, Messersmith H, Kaur V, Kirkwood JM, Kudchadkar R, McQuade JL, Provenzano A, Swami U, Weber J, Alluri KC, Agarwala S, Ascierto PA, Atkins MB, Davis N, Ernstoff MS, Faries MB, Gold JS, Guild S, Gyorki DE, Khushalani NI, Meyers MO, Robert C, Santinami M, Sehdev A, Sondak VK, Spurrier G, Tsai KK, van Akkooi A, Funchain P (2020) Systemic therapy for Melanoma: ASCO guideline. J Clin Oncol 38(33):3947\u20133970. https:\/\/doi.org\/10.1200\/JCO.20.00198","journal-title":"J Clin Oncol"},{"issue":"19","key":"1522_CR87","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1056\/NEJMoa1709030","volume":"377","author":"J Weber","year":"2017","unstructured":"Weber J, Mandala M, Del Vecchio M, Gogas HJ, Arance AM, Cowey CL, Dalle S, Schenker M, Chiarion-Sileni V, Marquez-Rodas I, Grob JJ, Butler MO, Middleton MR, Maio M, Atkinson V, Queirolo P, Gonzalez R, Kudchadkar RR, Smylie M, Meyer N, Mortier L, Atkins MB, Long GV, Bhatia S, Lebb\u00e9 C, Rutkowski P, Yokota K, Yamazaki N, Kim TM, de Pril V, Sabater J, Qureshi A, Larkin J, Ascierto PA (2017) CheckMate 238 Collaborators. Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma. N Engl J Med 377(19):1824\u20131835. https:\/\/doi.org\/10.1056\/NEJMoa1709030","journal-title":"N Engl J Med"},{"issue":"14","key":"1522_CR88","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1056\/NEJMoa1709684","volume":"377","author":"JD Wolchok","year":"2017","unstructured":"Wolchok JD, Chiarion-Sileni V, Gonzalez R, Rutkowski P, Grob JJ, Cowey CL, Lao CD, Wagstaff J, Schadendorf D, Ferrucci PF, Smylie M, Dummer R, Hill A, Hogg D, Haanen J, Carlino MS, Bechter O, Maio M, Marquez-Rodas I, Guidoboni M, McArthur G, Lebb\u00e9 C, Ascierto PA, Long GV, Cebon J, Sosman J, Postow MA, Callahan MK, Walker D, Rollin L, Bhore R, Hodi FS, Larkin J (2017) Overall survival with combined Nivolumab and Ipilimumab in advanced Melanoma. N Engl J Med 377(14):1345\u20131356. https:\/\/doi.org\/10.1056\/NEJMoa1709684","journal-title":"N Engl J Med"},{"issue":"11","key":"1522_CR89","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/S1470-2045(20)30494-0","volume":"21","author":"PA Ascierto","year":"2020","unstructured":"Ascierto PA, Del Vecchio M, Mandal\u00e1 M, Gogas H, Arance AM, Dalle S, Cowey CL, Schenker M, Grob JJ, Chiarion-Sileni V, M\u00e1rquez-Rodas I, Butler MO, Maio M, Middleton MR, de la Cruz-Merino L, Arenberger P, Atkinson V, Hill A, Fecher LA, Millward M, Khushalani NI, Queirolo P, Lobo M, de Pril V, Loffredo J, Larkin J, Weber J (2020) Adjuvant nivolumab versus ipilimumab in resected stage IIIB-C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial. Lancet Oncol 21(11):1465\u20131477. https:\/\/doi.org\/10.1016\/S1470-2045(20)30494-0","journal-title":"Lancet Oncol"},{"issue":"7","key":"1522_CR90","doi-asserted-by":"publisher","first-page":"e378","DOI":"10.1016\/S1470-2045(19)30332-8","volume":"20","author":"RN Amaria","year":"2019","unstructured":"Amaria RN, Menzies AM, Burton EM, Scolyer RA, Tetzlaff MT, Antdbacka R, Ariyan C, Bassett R, Carter B, Daud A, Faries M, Fecher LA, Flaherty KT, Gershenwald JE, Hamid O, Hong A, Kirkwood JM, Lo S, Margolin K, Messina J, Postow MA, Rizos H, Ross MI, Rozeman EA, Saw RPM, Sondak V, Sullivan RJ, Taube JM, Thompson JF, van de Wiel BA, Eggermont AM, Davies MA (2019) International Neoadjuvant Melanoma Consortium members, Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium. Lancet Oncol. 20(7):e378\u2013e389. https:\/\/doi.org\/10.1016\/S1470-2045(19)30332-8","journal-title":"Lancet Oncol."},{"issue":"10240","key":"1522_CR91","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/S0140-6736(20)30934-X","volume":"395","author":"R Gutzmer","year":"2020","unstructured":"Gutzmer R, Stroyakovskiy D, Gogas H, Robert C, Lewis K, Protsenko S, Pereira RP, Eigentler T, Rutkowski P, Demidov L, Manikhas GM, Yan Y, Huang KC, Uyei A, McNally V, McArthur GA, Ascierto PA (2020) Atezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAFV600mutation-positive melanoma (IMspire150): primary analysis of the randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 395(10240):1835\u20131844. https:\/\/doi.org\/10.1016\/S0140-6736(20)30934-X","journal-title":"Lancet"},{"issue":"3","key":"1522_CR92","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/s41416-020-01121-y","volume":"124","author":"P Bhave","year":"2021","unstructured":"Bhave P, Pallan L, Long GV, Menzies AM, Atkinson V, Cohen JV, Sullivan RJ, Chiarion-Sileni V, Nyakas M, Kahler K, Hauschild A, Plummer R, Trojaniello C, Ascierto PA, Zimmer L, Schadendorf D, Allayous C, Lebbe C, Maurichi A, Santinami M, Roy S, Robert C, Lesimple T, Patel S, Versluis JM, Blank CU, Khattak A, Van der Westhuizen A, Carlino MS, Shackleton M, Haydon A (2021) Melanoma recurrence patterns and management after adjuvant targeted therapy: a multicentre analysis. Br J Cancer 124(3):574\u2013580. https:\/\/doi.org\/10.1038\/s41416-020-01121-y","journal-title":"Br J Cancer"},{"issue":"26","key":"1522_CR93","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","volume":"364","author":"PB Chapman","year":"2011","unstructured":"Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J, Dummer R, Garbe C, Testori A, Maio M, Hogg D, Lorigan P, Lebbe C, Jouary T, Schadendorf D, Ribas A, O\u2019Day SJ, Sosman JA, Kirkwood JM, Eggermont AM, Dreno B, Nolop K, Li J, Nelson B, Hou J, Lee RJ, Flaherty KT, McArthur GA (2011) BRIM-3 Study Group Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 364(26):2507\u201316. https:\/\/doi.org\/10.1056\/NEJMoa1103782","journal-title":"N Engl J Med"},{"issue":"10","key":"1522_CR94","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1479-5876-10-85","volume":"9","author":"PA Ascierto","year":"2012","unstructured":"Ascierto PA, Kirkwood JM, Grob JJ, Simeone E, Grimaldi AM, Maio M, Palmieri G, Testori A, Marincola FM, Mozzillo N (2012) The role of BRAF V600 mutation in melanoma. J Transl Med 9(10):85. https:\/\/doi.org\/10.1186\/1479-5876-10-85","journal-title":"J Transl Med"},{"issue":"33","key":"1522_CR95","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1200\/JCO.20.02110","volume":"38","author":"AMM Eggermont","year":"2020","unstructured":"Eggermont AMM, Blank CU, Mandala M, Long GV, Atkinson VG, Dalle S, Haydon AM, Meshcheryakov A, Khattak A, Carlino MS, Sandhu S, Larkin J, Puig S, Ascierto PA, Rutkowski P, Schadendorf D, Koornstra R, Hernandez-Aya L, Di Giacomo AM, van den Eertwegh AJM, Grob JJ, Gutzmer R, Jamal R, Lorigan PC, van Akkooi ACJ, Krepler C, Ibrahim N, Marreaud S, Kicinski M, Suciu S, Robert C (2020) Longer follow-up confirms recurrence-free survival benefit of adjuvant Pembrolizumab in high-risk stage III Melanoma: updated results from the EORTC 1325-MG\/KEYNOTE-054 Trial. J Clin Oncol 38(33):3925\u20133936. https:\/\/doi.org\/10.1200\/JCO.20.02110","journal-title":"J Clin Oncol"},{"key":"1522_CR96","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ejca.2019.11.016","volume":"126","author":"PA Ascierto","year":"2020","unstructured":"Ascierto PA, Dummer R, Gogas HJ, Flaherty KT, Arance A, Mandala M, Liszkay G, Garbe C, Schadendorf D, Krajsova I, Gutzmer R, de Groot JWB, Loquai C, Gollerkeri A, Pickard MD, Robert C (2020) Update on tolerability and overall survival in COLUMBUS: landmark analysis of a randomised phase 3 trial of encorafenib plus binimetinib vs vemurafenib or encorafenib in patients with BRAF V600-mutant melanoma. Eur J Cancer 126:33\u201344. https:\/\/doi.org\/10.1016\/j.ejca.2019.11.016","journal-title":"Eur J Cancer"},{"issue":"6","key":"1522_CR97","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/s41591-019-0448-9","volume":"25","author":"PA Ascierto","year":"2019","unstructured":"Ascierto PA, Ferrucci PF, Fisher R, Del Vecchio M, Atkinson V, Schmidt H, Schachter J, Queirolo P, Long GV, Di Giacomo AM, Svane IM, Lotem M, Bar-Sela G, Couture F, Mookerjee B, Ghori R, Ibrahim N, Moreno BH, Ribas A (2019) Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma. Nat Med 25(6):941\u2013946. https:\/\/doi.org\/10.1038\/s41591-019-0448-9","journal-title":"Nat Med"},{"issue":"1","key":"1522_CR98","doi-asserted-by":"publisher","first-page":"6262","DOI":"10.1038\/s41467-020-19810-w","volume":"11","author":"A Ribas","year":"2020","unstructured":"Ribas A, Algazi A, Ascierto PA, Butler MO, Chandra S, Gordon M, Hernandez-Aya L, Lawrence D, Lutzky J, Miller WH Jr, Campbell KM, Delafont B, Marshall S, Mueller N, Robert C (2020) PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma. Nat Commun 11(1):6262. https:\/\/doi.org\/10.1038\/s41467-020-19810-w","journal-title":"Nat Commun"},{"issue":"7","key":"1522_CR99","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1148\/rg.2017170085","volume":"37","author":"GX Wang","year":"2017","unstructured":"Wang GX, Kurra V, Gainor JF, Sullivan RJ, Flaherty KT, Lee SI, Fintelmann FJ (2017) Immune Checkpoint Inhibitor Cancer Therapy: Spectrum of Imaging Findings. Radiographics 37(7):2132\u20132144. https:\/\/doi.org\/10.1148\/rg.2017170085","journal-title":"Radiographics"},{"issue":"2","key":"1522_CR100","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s12254-018-0389-x","volume":"11","author":"L Beer","year":"2018","unstructured":"Beer L, Hochmair M, Prosch H (2018) Pitfalls in the radiological response assessment of immunotherapy. Memo 11(2):138\u2013143. https:\/\/doi.org\/10.1007\/s12254-018-0389-x","journal-title":"Memo"},{"issue":"5","key":"1522_CR101","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1148\/rg.335125214","volume":"33","author":"T Tirkes","year":"2013","unstructured":"Tirkes T, Hollar MA, Tann M, Kohli MD, Akisik F, Sandrasegaran K (2013) Response criteria in oncologic imaging: review of traditional and new criteria. Radiographics. 33(5):1323\u201341. https:\/\/doi.org\/10.1148\/rg.335125214","journal-title":"Radiographics."},{"issue":"26","key":"1522_CR102","doi-asserted-by":"publisher","first-page":"4767","DOI":"10.3748\/wjg.v23.i26.4767","volume":"23","author":"V Granata","year":"2017","unstructured":"Granata V, Fusco R, Setola SV, Piccirillo M, Leongito M, Palaia R, Granata F, Lastoria S, Izzo F, Petrillo A (2017) Early radiological assessment of locally advanced pancreatic cancer treated with electrochemotherapy. World J Gastroenterol 23(26):4767\u20134778. https:\/\/doi.org\/10.3748\/wjg.v23.i26.4767","journal-title":"World J Gastroenterol"},{"key":"1522_CR103","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ijsu.2015.04.055","volume":"18","author":"V Granata","year":"2015","unstructured":"Granata V, Fusco R, Piccirillo M, Palaia R, Petrillo A, Lastoria S, Izzo F (2015) Electrochemotherapy in locally advanced pancreatic cancer: Preliminary results. Int J Surg 18:230\u2013236. https:\/\/doi.org\/10.1016\/j.ijsu.2015.04.055","journal-title":"Int J Surg"},{"issue":"2","key":"1522_CR104","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"E Eisenhauer","year":"2009","unstructured":"Eisenhauer E et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45(2):228\u201347","journal-title":"Eur J Cancer"},{"issue":"10","key":"1522_CR105","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.560952","volume":"27","author":"V Granata","year":"2020","unstructured":"Granata V, Grassi R, Fusco R, Setola SV, Palaia R, Belli A, Miele V, Brunese L, Grassi R, Petrillo A, Izzo F (2020) Assessment of Ablation Therapy in pancreatic cancer: the radiologist\u2019s challenge. Front Oncol 27(10):560952. https:\/\/doi.org\/10.3389\/fonc.2020.560952","journal-title":"Front Oncol"},{"issue":"23","key":"1522_CR106","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.3748\/wjg.v27.i23.3413","volume":"27","author":"V Granata","year":"2021","unstructured":"Granata V, Grassi R, Fusco R, Belli A, Palaia R, Carrafiello G, Miele V, Grassi R, Petrillo A, Izzo F (2021) Local ablation of pancreatic tumors: State of the art and future perspectives. World J Gastroenterol 27(23):3413\u20133428. https:\/\/doi.org\/10.3748\/wjg.v27.i23.3413","journal-title":"World J Gastroenterol"},{"issue":"23","key":"1522_CR107","doi-asserted-by":"publisher","first-page":"7412","DOI":"10.1158\/1078-0432.CCR-09-1624","volume":"15","author":"JD Wolchok","year":"2009","unstructured":"Wolchok JD, Hoos A, O\u2019Day S, Weber JS, Hamid O, Lebb\u00e9 C, Maio M, Binder M, Bohnsack O, Nichol G, Humphrey R, Hodi FS (2009) Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria. Clin Cancer Res 15(23):7412\u20137420. https:\/\/doi.org\/10.1158\/1078-0432.CCR-09-1624","journal-title":"Clin Cancer Res"},{"issue":"3","key":"1522_CR108","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/annonc\/mdz003","volume":"30","author":"E Borcoman","year":"2019","unstructured":"Borcoman E, Kanjanapan Y, Champiat S, Kato S, Servois V, Kurzrock R, Goel S, Bedard P, Le Tourneau C (2019) Novel patterns of response under immunotherapy. Ann Oncol 30(3):385\u2013396. https:\/\/doi.org\/10.1093\/annonc\/mdz003","journal-title":"Ann Oncol"},{"issue":"14","key":"1522_CR109","doi-asserted-by":"publisher","first-page":"3936","DOI":"10.1158\/1078-0432.CCR-13-0895","volume":"19","author":"M Nishino","year":"2013","unstructured":"Nishino M, Giobbie-Hurder A, Gargano M et al (2013) Developing a common language for tumor response to immunotherapy: immune-related re- sponse criteria using unidimensional measurements. Clin Cancer Res 19(14):3936\u20133943","journal-title":"Clin Cancer Res"},{"issue":"3","key":"1522_CR110","doi-asserted-by":"publisher","first-page":"e143","DOI":"10.1016\/S1470-2045(17)30074-8","volume":"18","author":"L Seymour","year":"2017","unstructured":"Seymour L, Bogaerts J, Perrone A et al (2017) iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics. Lancet Oncol 18(3):e143\u2013e152","journal-title":"Lancet Oncol"},{"issue":"4","key":"1522_CR111","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11912-020-0897-9","volume":"22","author":"EP Darnell","year":"2020","unstructured":"Darnell EP, Mooradian MJ, Baruch EN, Yilmaz M, Reynolds KL (2020) Immune-Related Adverse Events (irAEs): diagnosis, Management, and Clinical Pearls. Curr Oncol Rep 22(4):39. https:\/\/doi.org\/10.1007\/s11912-020-0897-9","journal-title":"Curr Oncol Rep"},{"key":"1522_CR112","unstructured":"Common terminology criteria for adverse events (CTCAE) V5. Available: https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_ applications\/ctc.htm"},{"key":"1522_CR113","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/ijc.32132","volume":"145","author":"P Arnaud-Coffin","year":"2019","unstructured":"Arnaud-Coffin P, Maillet D, Gan HK et al (2019) A systematic review of adverse events in randomized trials assessing immune checkpoint inhibitors. Int J Cancer 145:639\u2013648","journal-title":"Int J Cancer"},{"issue":"4","key":"1522_CR114","doi-asserted-by":"publisher","first-page":"MMT30","DOI":"10.2217\/mmt-2019-0005","volume":"6","author":"E Simeone","year":"2019","unstructured":"Simeone E, Grimaldi AM, Festino L, Trojaniello C, Vitale MG, Vanella V, Palla M, Ascierto PA (2019) Immunotherapy in metastatic melanoma: a novel scenario of new toxicities and their management. Melanoma Manag 6(4):MMT30. https:\/\/doi.org\/10.2217\/mmt-2019-0005","journal-title":"Melanoma Manag"},{"issue":"1","key":"1522_CR115","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1148\/radiol.2018181349","volume":"290","author":"M Nishino","year":"2019","unstructured":"Nishino M, Hatabu H, Hodi FS (2019) Imaging of cancer immunotherapy: current approaches and future directions. Radiology 290(1):9\u201322. https:\/\/doi.org\/10.1148\/radiol.2018181349","journal-title":"Radiology"},{"issue":"6","key":"1522_CR116","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002435","volume":"9","author":"JR Brahmer","year":"2021","unstructured":"Brahmer JR, Abu-Sbeih H, Ascierto PA, Brufsky J, Cappelli LC, Cortazar FB, Gerber DE, Hamad L, Hansen E, Johnson DB, Lacouture ME, Masters GA, Naidoo J, Nanni M, Perales MA, Puzanov I, Santomasso BD, Shanbhag SP, Sharma R, Skondra D, Sosman JA, Turner M, Ernstoff MS (2021) Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events. J Immunother Cancer 9(6):e002435. https:\/\/doi.org\/10.1136\/jitc-2021-002435","journal-title":"J Immunother Cancer"},{"issue":"5","key":"1522_CR117","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1001\/jamaoncol.2016.6611","volume":"3","author":"DE Comstock","year":"2017","unstructured":"Comstock DE, Nishino M, Giardino AA (2017) Headache in the setting of immuno- therapy treatment for metastatic melanoma. JAMA Oncol 3(5):703\u2013704","journal-title":"JAMA Oncol"},{"issue":"11","key":"1522_CR118","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1210\/jc.2014-2306","volume":"99","author":"AT Faje","year":"2014","unstructured":"Faje AT, Sullivan R, Lawrence D et al (2014) Ipilimumab-induced hypophysitis: a detailed longitudinal analysis in a large cohort of patients with metastatic melanoma. J Clin Endocrinol Metab 99(11):4078\u20134085","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1522_CR119","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1158\/1078-0432.CCR-14-2353","volume":"21","author":"L Min","year":"2015","unstructured":"Min L, Hodi FS, Giobbie-Hurder A et al (2015) Systemic high-dose corticosteroid treatment does not improve the outcome of ipilimumab-related hypophysitis: a retrospective cohort study. Clin Cancer Res 21(4):749\u2013755","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1522_CR120","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.chest.2017.04.177","volume":"152","author":"M Khunger","year":"2017","unstructured":"Khunger M, Rakshit S, Pasupuleti V, Hernandez AV, Mazzone P, Stevenson J, Pennell NA, Velcheti V (2017) Incidence of pneumonitis with use of programmed death 1 and programmed Death-Ligand 1 inhibitors in non-small cell lung cancer: a systematic review and meta-analysis of trials. Chest 152(2):271\u2013281. https:\/\/doi.org\/10.1016\/j.chest.2017.04.177","journal-title":"Chest"},{"issue":"7","key":"1522_CR121","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1148\/rg.2019190036","volume":"39","author":"KR Kalisz","year":"2019","unstructured":"Kalisz KR, Ramaiya NH, Laukamp KR, Gupta A (2019) Immune Checkpoint Inhibitor Therapy-related Pneumonitis: patterns and management. Radiographics 39(7):1923\u20131937. https:\/\/doi.org\/10.1148\/rg.2019190036","journal-title":"Radiographics"},{"issue":"4","key":"1522_CR122","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/s11547-020-01313-9","volume":"126","author":"A Bianchi","year":"2021","unstructured":"Bianchi A, Mazzoni LN, Busoni S, Pinna N, Albanesi M, Cavigli E, Cozzi D, Poggesi A, Miele V, Fainardi E, Gadda D (2021) Assessment of cerebrovascular disease with computed tomography in COVID-19 patients: correlation of a novel specific visual score with increased mortality risk. Radiol Med 126(4):570\u2013576. https:\/\/doi.org\/10.1007\/s11547-020-01313-9","journal-title":"Radiol Med"},{"issue":"4","key":"1522_CR123","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1007\/s11547-020-01292-x","volume":"126","author":"G Cartocci","year":"2021","unstructured":"Cartocci G, Colaiacomo MC, Lanciotti S, Andreoli C, De Cicco ML, Brachetti G, Pugliese S, Capoccia L, Tortora A, Scala A, Valentini C, Almberger M, D\u2019Aprile MR, Avventurieri G, Giura R, Kharrub Z, Leonardi A, Boccia M, Catalano C, Ricci P (2021) Correction to: Chest CT for early detection and management of coronavirus disease (COVID-19): a report of 314 patients admitted to Emergency Department with suspected pneumonia. Radiol Med 126(4):642. https:\/\/doi.org\/10.1007\/s11547-020-01292-x","journal-title":"Radiol Med"},{"issue":"1\u20132","key":"1522_CR124","first-page":"12","volume":"99","author":"M Zompatori","year":"2000","unstructured":"Zompatori M, Poletti V, Battista G, Schiavina M, Fadda E, Tetta C (2000) Diffuse cystic lung disease in the adult patient. Radiol Med 99(1\u20132):12\u201321","journal-title":"Radiol Med"},{"issue":"9","key":"1522_CR125","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1007\/s11547-021-01371-7","volume":"126","author":"GM Masci","year":"2021","unstructured":"Masci GM, Iafrate F, Ciccarelli F, Pambianchi G, Panebianco V, Pasculli P, Ciardi MR, Mastroianni CM, Ricci P, Catalano C, Francone M (2021) Tocilizumab effects in COVID-19 pneumonia: role of CT texture analysis in quantitative assessment of response to therapy. Radiol Med 126(9):1170\u20131180. https:\/\/doi.org\/10.1007\/s11547-021-01371-7","journal-title":"Radiol Med"},{"issue":"5","key":"1522_CR126","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s11547-021-01338-8","volume":"126","author":"G Francolini","year":"2021","unstructured":"Francolini G, Desideri I, Stocchi G, Ciccone LP, Salvestrini V, Garlatti P, Aquilano M, Greto D, Bonomo P, Meattini I, Scotti V, Scoccianti S, Simontacchi G, Livi L (2021) Impact of COVID-19 on workload burden of a complex radiotherapy facility. Radiol Med 126(5):717\u2013721. https:\/\/doi.org\/10.1007\/s11547-021-01338-8","journal-title":"Radiol Med"},{"issue":"2","key":"1522_CR127","doi-asserted-by":"publisher","first-page":"1700050","DOI":"10.1183\/13993003.00050-2017","volume":"50","author":"M Delaunay","year":"2017","unstructured":"Delaunay M, Cadranel J, Lusque A, Meyer N, Gounant V, Moro-Sibilot D, Michot JM, Raimbourg J, Girard N, Guisier F, Planchard D, Metivier AC, Tomasini P, Dansin E, P\u00e9rol M, Campana M, Gautschi O, Fr\u00fch M, Fumet JD, Audigier-Valette C, Couraud S, Dalle S, Leccia MT, Jaffro M, Collot S, Pr\u00e9vot G, Milia J, Mazieres J (2017) Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients. Eur Respir J 50(2):1700050. https:\/\/doi.org\/10.1183\/13993003.00050-2017","journal-title":"Eur Respir J"}],"container-title":["La radiologia medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-022-01522-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11547-022-01522-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-022-01522-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T12:28:22Z","timestamp":1659529702000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11547-022-01522-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,14]]},"references-count":127,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["1522"],"URL":"https:\/\/doi.org\/10.1007\/s11547-022-01522-4","relation":{},"ISSN":["1826-6983"],"issn-type":[{"type":"electronic","value":"1826-6983"}],"subject":[],"published":{"date-parts":[[2022,7,14]]},"assertion":[{"value":"19 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflict of interest to be disclosed. The authors confirm that the article is not under consideration for publication elsewhere. Each author has participated sufficiently in any submission to take public responsibility for its content.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human participants and animals"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}